213 related articles for article (PubMed ID: 17003496)
1. Hyaluronidase expression induces prostate tumor metastasis in an orthotopic mouse model.
Kovar JL; Johnson MA; Volcheck WM; Chen J; Simpson MA
Am J Pathol; 2006 Oct; 169(4):1415-26. PubMed ID: 17003496
[TBL] [Abstract][Full Text] [Related]
2. HYAL1 hyaluronidase in prostate cancer: a tumor promoter and suppressor.
Lokeshwar VB; Cerwinka WH; Isoyama T; Lokeshwar BL
Cancer Res; 2005 Sep; 65(17):7782-9. PubMed ID: 16140946
[TBL] [Abstract][Full Text] [Related]
3. Orthotopic treatment model of prostate cancer and metastasis in the immunocompetent mouse: efficacy of flt3 ligand immunotherapy.
Somers KD; Brown RR; Holterman DA; Yousefieh N; Glass WF; Wright GL; Schellhammer PF; Qian J; Ciavarra RP
Int J Cancer; 2003 Dec; 107(5):773-80. PubMed ID: 14566827
[TBL] [Abstract][Full Text] [Related]
4. Reduced c-Met expression by an adenovirus expressing a c-Met ribozyme inhibits tumorigenic growth and lymph node metastases of PC3-LN4 prostate tumor cells in an orthotopic nude mouse model.
Kim SJ; Johnson M; Koterba K; Herynk MH; Uehara H; Gallick GE
Clin Cancer Res; 2003 Nov; 9(14):5161-70. PubMed ID: 14613995
[TBL] [Abstract][Full Text] [Related]
5. Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis.
Wong SY; Haack H; Crowley D; Barry M; Bronson RT; Hynes RO
Cancer Res; 2005 Nov; 65(21):9789-98. PubMed ID: 16267000
[TBL] [Abstract][Full Text] [Related]
6. A novel mouse model of human prostate cancer to study intraprostatic tumor growth and the development of lymph node metastases.
Linxweiler J; Körbel C; Müller A; Hammer M; Veith C; Bohle RM; Stöckle M; Junker K; Menger MD; Saar M
Prostate; 2018 Jun; 78(9):664-675. PubMed ID: 29572953
[TBL] [Abstract][Full Text] [Related]
7. Spontaneous metastasis of prostate cancer is promoted by excess hyaluronan synthesis and processing.
Bharadwaj AG; Kovar JL; Loughman E; Elowsky C; Oakley GG; Simpson MA
Am J Pathol; 2009 Mar; 174(3):1027-36. PubMed ID: 19218337
[TBL] [Abstract][Full Text] [Related]
8. Systemic interleukin 2 therapy for human prostate tumors in a nude mouse model.
Triest JA; Grignon DJ; Cher ML; Kocheril SV; Montecillo EJ; Talati B; Tekyi-Mensah S; Pontes JE; Hillman GG
Clin Cancer Res; 1998 Aug; 4(8):2009-14. PubMed ID: 9717832
[TBL] [Abstract][Full Text] [Related]
9. Concurrent expression of hyaluronan biosynthetic and processing enzymes promotes growth and vascularization of prostate tumors in mice.
Simpson MA
Am J Pathol; 2006 Jul; 169(1):247-57. PubMed ID: 16816377
[TBL] [Abstract][Full Text] [Related]
10. Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice.
Pettaway CA; Pathak S; Greene G; Ramirez E; Wilson MR; Killion JJ; Fidler IJ
Clin Cancer Res; 1996 Sep; 2(9):1627-36. PubMed ID: 9816342
[TBL] [Abstract][Full Text] [Related]
11. Real-time whole-body imaging of an orthotopic metastatic prostate cancer model expressing red fluorescent protein.
Yang M; Jiang P; Yamamoto N; Li L; Geller J; Moossa AR; Hoffman RM
Prostate; 2005 Mar; 62(4):374-9. PubMed ID: 15389802
[TBL] [Abstract][Full Text] [Related]
12. Genetic abnormalities specifically associated with varying metastatic potential of prostate cancer cell lines as detected by comparative genomic hybridization.
Chu LW; Pettaway CA; Liang JC
Cancer Genet Cytogenet; 2001 Jun; 127(2):161-7. PubMed ID: 11425457
[TBL] [Abstract][Full Text] [Related]
13. HYAL1 overexpression is correlated with the malignant behavior of human breast cancer.
Tan JX; Wang XY; Li HY; Su XL; Wang L; Ran L; Zheng K; Ren GS
Int J Cancer; 2011 Mar; 128(6):1303-15. PubMed ID: 20473947
[TBL] [Abstract][Full Text] [Related]
14. Prostate cancer treatment is enhanced by genistein in vitro and in vivo in a syngeneic orthotopic tumor model.
Wang Y; Raffoul JJ; Che M; Doerge DR; Joiner MC; Kucuk O; Sarkar FH; Hillman GG
Radiat Res; 2006 Jul; 166(1 Pt 1):73-80. PubMed ID: 16808622
[TBL] [Abstract][Full Text] [Related]
15. HYAL1 hyaluronidase: a molecular determinant of bladder tumor growth and invasion.
Lokeshwar VB; Cerwinka WH; Lokeshwar BL
Cancer Res; 2005 Mar; 65(6):2243-50. PubMed ID: 15781637
[TBL] [Abstract][Full Text] [Related]
16. A cervical lymph node metastatic model of human tongue carcinoma: Serial and orthotopic transplantation of histologically intact patient specimens in nude mice.
Qiu C; Wu H; He H; Qiu W
J Oral Maxillofac Surg; 2003 Jun; 61(6):696-700. PubMed ID: 12796881
[TBL] [Abstract][Full Text] [Related]
17. A metastatic and androgen-sensitive human prostate cancer model using intraprostatic inoculation of LNCaP cells in SCID mice.
Sato N; Gleave ME; Bruchovsky N; Rennie PS; Beraldi E; Sullivan LD
Cancer Res; 1997 Apr; 57(8):1584-9. PubMed ID: 9108464
[TBL] [Abstract][Full Text] [Related]
18. Improved metastatic animal model of human prostate carcinoma using surgical orthotopic implantation (SOI).
Chang XH; Fu YW; Na WL; Wang J; Sun H; Cai L
Anticancer Res; 1999; 19(5B):4199-202. PubMed ID: 10628375
[TBL] [Abstract][Full Text] [Related]
19. Surgical orthotopic implantation allows high lung and lymph node metastatic expression of human prostate carcinoma cell line PC-3 in nude mice.
An Z; Wang X; Geller J; Moossa AR; Hoffman RM
Prostate; 1998 Feb; 34(3):169-74. PubMed ID: 9492844
[TBL] [Abstract][Full Text] [Related]
20. Model for mediastinal lymph node metastasis produced by orthotopic intrapulmonary implantation of lung cancer cells in mice.
Yamaura T; Doki Y; Murakami K; Saiki I
Hum Cell; 1999 Dec; 12(4):197-204. PubMed ID: 10834106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
